InvestSMART

Burgundy Diamond Mines Limited (ASX: BDM) - Announcements

- Current share price for BDM : $0.017

ASX company news and announcements for Burgundy Diamond Mines Limited (BDM) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Burgundy Diamond Mines Limited (BDM) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Burgundy Diamond Mines Limited (BDM), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Burgundy Diamond Mines Limited (BDM)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$24 BioDiem receives FDA Orphan Drug Designation for BDM-E 9 Sep 2010 12:49PM n/a $0.017 n/a
$24 Full Year Statutory Accounts 19 Aug 2010 3:22PM n/a $0.017 n/a
$24 Appendix 4C - quarterly 30 Jul 2010 5:12PM $0.140 $0.017 fallen by 87.86%
$24 Live Attenuated Influenza Vaccine Launched in India 12 Jul 2010 9:49AM n/a $0.017 n/a
$24 Appendix 4C - quarterly 30 Apr 2010 12:40PM n/a $0.017 n/a
$24 Non-Renounceable Pro-Rata Rights Issue Prospectus 26 Mar 2010 10:32AM $0.185 $0.017 fallen by 90.81%
$24 Non-Renounceable Issue 25 Mar 2010 11:44AM $0.185 $0.017 fallen by 90.81%
$24 Half Year Results 26 Feb 2010 2:54PM n/a $0.017 n/a
$24 Half Yearly Report and Accounts 26 Feb 2010 2:07PM n/a $0.017 n/a
$24 Letter to Shareholders 26 Feb 2010 10:03AM n/a $0.017 n/a
$24 Appendix 4C - quarterly 29 Jan 2010 2:44PM $0.200 $0.017 fallen by 91.50%
$24 BioDiem regains Japanese rights to LAIV 24 Dec 2009 11:16AM $0.210 $0.017 fallen by 91.90%
$24 Extension of Co-operative Research Development Agreement 27 Oct 2009 11:59AM $0.210 $0.017 fallen by 91.90%
$24 WHO issues a further sublicence of LAIV 27 Oct 2009 11:58AM $0.210 $0.017 fallen by 91.90%
$24 Appendix 4C - quarterly 22 Oct 2009 10:36AM $0.200 $0.017 fallen by 91.50%
$24 LAIV Proof of Concept Trial 14 Oct 2009 9:48AM n/a $0.017 n/a
$24 WHO Sub-licences BioDiem`s LAIV Technology 2 Sep 2009 11:56AM $0.210 $0.017 fallen by 91.90%
$24 Agreement with PATH for Prototype Pandemic Influenza Vaccine 1 Sep 2009 11:02AM $0.160 $0.017 fallen by 89.38%
$24 Completion of Phase I Clinical Trial Recruitment for LAIV 31 Aug 2009 10:38AM n/a $0.017 n/a
$24 Preliminary Final Report 19 Aug 2009 4:19PM $0.120 $0.017 fallen by 85.83%
$24 Appendix 4C - quarterly 31 Jul 2009 3:34PM n/a $0.017 n/a
$24 BioDiem supports WHO`s Global Pandemic Influenza Action Plan 25 May 2009 10:43AM $0.130 $0.017 fallen by 86.92%
$24 Appendix 4C - quarterly 28 Apr 2009 10:23AM $0.150 $0.017 fallen by 88.67%
$24 Half Year Financial Reports 26 Feb 2009 10:32AM n/a $0.017 n/a
$24 Commencement of Phase I clinical trials for LAIV 24 Feb 2009 4:12PM $0.070 $0.017 fallen by 75.71%

376 - 400 of 458 results

Page 16 of 19

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.